维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="Deitcher S"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Use of a eonstitutivel'y active hypoxia-inducible factor-lalpha transgene as a therapeutic strategy in no-option critical limb ischemia patients: phase I dose-escalation experience显示文摘	Rajagopalan S Olin J Deitcher S	2007	Circulation2007，115，10：	1
2	Treament of occluded central ve- nous catheters with aheplase: results in 1 064 patients显示文摘	SEMBA C P DEITCHER S R LI X	2002	Vasc Intev Radiol2002，13，12：	1
3	Use of a constitutively ac-tive hypoxia-inducible factor-1 alpha transgene as a therapeutic strat-egy in no-option critical limb ischemia patients: phase 1 dose-es-calation experience 显示文摘	Rajagopalan S 01in J Deitcher S	2007	Circulation2007，115，10：	1
4	Treatment of occluded central venous catheters with alteplase: Results in 1,064 patients显示文摘	Semba C P Deitcher S R Li X	2002	Vase Interv Radiol2002，13，12：	1
5	Use of a constitutively ac-tive hypoxia-inducible factor-1 alpha transgene as a therapeutic strat-egy in no-option critical limb ischemia patients: phase 1 dose-es-calation experience 显示文摘	Rajagopalan S 01in J Deitcher S	2007	Circulation2007，115，10：	1
6	The Risk of Venous Thromboembolism Disease Associated with Adjuvant Hormone Therapy for Breast Carcinoma显示文摘	Deitcher S Gomes M	2004	Cancer2004，101，3：	1
7	Clinical utility of subcutaneous hirudins显示文摘	Deitcher S	2003	Am J Health Syst Pharm2003，60，5：	1
8	Use of a constitutively active hypoxia-inducible factor-1 alpha transgene as a therapeutic strategy in no-option critical limb ischemia patients: phase I dose- escalation experience 显示文摘	Rajagopalan S Olin J Deitcher S	2007	Circulation2007，115，10：	1
9	Plasminogen activator inhibitor type-1(PAI-1)polymorphism 4G/5G is associated with prostate cancer among men with a positive family history显示文摘	Jorgenson E Deitcher S R Cicek M	2007	Prostate2007，67，2：	1
10	Use of a constitutively active hypoxia-inducible factor-I alpha transgene as a therapeutic strategy in no-option critical limb ischemia patients: phase I dose escalation experience 显示文摘	Rajagopalan S Olin J Deitcher S		Circulation0，115，10：	1
11	Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss显示文摘	Kutteh W Park V and Deitcher S	1999	Fertil Steril1999，71，6：	1
12	Use of a constitutively active hypoxia-inducible factor-1alpha transgene as a therapeutic strategy in no-option critical limb ischemia patients:phase I dose-escalation experience显示文摘	Rajagopalan S Olin J Deitcher S	2007	Circulation2007，115，10：	1
13	Clinical utility of subcutaneous hirudins显示文摘	Deitcher S R	2003	Am J Health Syst Pharm2003，60，5：	1
14	Developmental and regional expression pattern of a novel NMDA receptor-like sub- unit (NMDAR-L) in the rodent brain显示文摘	Sucher NJ Akbarian S Chi CL Leclerc CL Awobu- luyi M Deitcher DL	1995	J Neurosci1995，15，10：	1
15	Long term results of a phase 2 study of vincristine sulfate liposome injection(MarqiboR) substituted for non-liposomal vincristine in cyclophosphamide,doxorubicin,vincristine,prednisone with or without rituximab for patients with untreated aggressive non-Hodgkin lymphomas显示文摘	Hagemeister F B Rodriguez M A Deitcher S R	2013	Blood2013，122，21：	1
16	Use of a constitutively active hypoxia-inducible factor-lalpha transgene as a therapeutic strategy in no-optioneritica显示文摘	Rajagopalan S Olin J Deitcher S	2007	Circulation2007，，10：	1
17	Use of a constitutively active hypoxia-inducible factor-lalpha transgene as a therapeutic strategy in no-option critical limb ischemia patients: phase Ⅰ doseescalation experience 显示文摘	Rajagopalan S Olin J Deitcher S	2007	Circulation2007，115，10：	1
18	Safety and efficiency of alfimeprase for restoring function in occluded central venous catheters:interim results of a phase 2,multicenter,randomized,double-blind study (NuCath)显示文摘	Deitcher S R Moll S Homesley H D	2004	Blood(ASH Annual Meeting Abstracts)2004，104，11：	1
19	Marqibo? (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine 显示文摘	Silverman J A Deitcher S R	2013	Cancer Chemother Pharmacol2013，71，3：	1
20	Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-L) in the rodent brain 显示文摘	Sucher NJ Akbarian S Chi CL Leclerc CL Awobuluyi M Deitcher DL	1995	J Neurosci1995，15，10：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示